Senior insider sale
EVP and CFO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$2.97M
6.50K shares
What this filing means
WAGNER CHARLES F JR plans to sell 6.50K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $2.97M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/3/2024ACC: 0001959173-24-004075
Officer· EVP and CFO
Since Apr 2019
6.50K
Shares to sell
$2.97M
Approx. market value
3.25K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
Restricted Stock Vesting
Compensation
2/17/2023
1.75KRestricted Stock Vesting
Compensation
2/13/2023
615.00Restricted Stock Vesting
Compensation
2/10/2023
889.00Total acquired3.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2023 | Restricted Stock Vesting Compensation | 1.75K | — |
2/13/2023 | Restricted Stock Vesting Compensation | 615.00 | — |
2/10/2023 | Restricted Stock Vesting Compensation | 889.00 | — |
| Total | 3.25K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.25K
Market value
$1.48M
5/28/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.25K
Market value
$1.50M
6/3/2024
Total
Units
6.50K
Value
$2.97M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/28/2024 | 3.25K | $1.48M | — | Completed |
| Planned — Approximate Date | ||||
6/3/2024 | 3.25K | $1.50M | NASDAQ | Planned |
| Total | 6.50K | $2.97M | ||